In vitro activation of bronchoalveolar lavage cells by house dust mite allergens.
Mast cells represent a small but important proportion of bronchoalveolar lavage cells and are directly exposed to environmental triggers including allergens. Histamine and PGD2 are mediators released during the activation of mast cells. Fourteen patients allergic to Dermatophagoides pteronyssinus were studied. After bronchoalveolar lavage the unfractionated cell pellet containing metachromatic cells was submitted to allergen challenge using three concentrations of a standardized Dermatophagoides pteronyssinus extract and one concentration of A23187 (2.5 microM). The release of histamine was measured by radioimmunoassay using a monoclonal antibody against acylated histamine and PGD2 was measured by enzyme immunoassay using a polyclonal antibody against methoxamine-PGD2. Histamine was released in 13/14 patients following stimulation of the cells with A23187 and 12/14 patients after stimulation with Dermatophagoides pteronyssinus extract. The release of histamine was 3.5-fold greater when cells were stimulated by the Dermatophagoides pteronyssinus extract than with A23187. PGD2 was released in 10/12 patients when cells were stimulated with A23187 and 6/14 patients in the case of Dermatophagoides pteronyssinus extract stimulation. In the latter case, the mean release was not significantly greater than baseline. For histamine, the maximum release usually occurred with the more concentrated extract whereas in the experiments where PGD2 was released, maximal generation usually occurred with the lowest concentration used. There was no correlation between the severity of asthma and the release of mediators. This study confirms the activation of metachromatic cells by allergen and shows some heterogeneity in the release of granule and membrane-derived mediators.
Clinique des Maladies Respiratoires, Hopital I'Aiguelongue, Montpellier, France.
A M
AM
Campbell
P
P
Chanez
I
I
Couret
P
P
Godard
F B
FB
Michel
J
J
Bousquet
D000328:Adult; D000485:Allergens / Q000008:administration & dosage*; D000818:Animals; D039741:Antigens, Dermatophagoides; D001249:Asthma / Q000276:immunology / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology* / Q000378:metabolism; D000001:Calcimycin / Q000494:pharmacology; D005541:Forced Expiratory Volume; D006636:Histamine Release; D006801:Humans; D008875:Middle Aged; D008925:Mites / Q000276:immunology*; D015230:Prostaglandin D2 / Q000378:metabolism; D012720:Severity of Illness Index
D000485:Allergens; D039741:Antigens, Dermatophagoides; D000001:Calcimycin; D015230:Prostaglandin D2